Capecitabine leukoencephalopathy

Pract Neurol. 2019 Jun;19(3):270-271. doi: 10.1136/practneurol-2018-002121. Epub 2019 Jan 5.

Authors

Zeid Yasiry¹, Mahdia S Obeda², Ruth Batty³, Basil Sharrack⁴

Affiliations

¹ Department of Neurology, Sheffield Teaching Hospital NHS Trust, Royal Hallamshire Hospital, Sheffield, UK zeid.yasiry@nhs.net.
² University of Sheffield Medical School, Sheffield, UK.
³ Sheffield Teaching Hospital NHS Trust, Sheffield, UK.
⁴ Department of Neurology, Sheffield Teaching Hospital NHS Trust, Royal Hallamshire Hospital, Sheffield, UK.

PMID: 30612099
DOI: 10.1136/practneurol-2018-002121

No abstract available

Keywords: leukoencephalopathy; neuro-oncology; neuroradiology; neurotoxicology.

Publication types

Case Reports

MeSH terms

Antimetabolites, Antineoplastic / adverse effects*
Capecitabine / adverse effects*
Humans
Leukoencephalopathies / chemically induced*
Leukoencephalopathies / diagnostic imaging*
Male
Middle Aged

Substances

Antimetabolites, Antineoplastic
Capecitabine